Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Dec 19, 2025
- Accession no.
- 0001106578-25-000042
- Filed
- Dec 19, 2025
- Trade date
- Dec 17-19, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 10 non-derivative transactions and 3 derivative transactions. Open-market sales total $5.05M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | Common Stock | MOption exerciseAcquired | +4,000 | $120.26 | +$481,040 | 4,130 | Direct | |
| Dec 17, 2025 | Common Stock | SSaleDisposed | −1,500 | $500.52F2 | −$750,780 | 2,630 | Direct | |
| Dec 17, 2025 | Common Stock | SSaleDisposed | −2,500 | $501.35F3 | −$1,253,375 | 130 | Direct | |
| Dec 18, 2025 | Common Stock | MOption exerciseAcquired | +4,000 | $120.26 | +$481,040 | 4,130 | Direct | |
| Dec 18, 2025 | Common Stock | SSaleDisposed | −2,000 | $507.24F4 | −$1,014,480 | 2,130 | Direct | |
| Dec 18, 2025 | Common Stock | SSaleDisposed | −500 | $509.42 | −$254,710 | 1,630 | Direct | |
| Dec 18, 2025 | Common Stock | SSaleDisposed | −1,500 | $510.86F5 | −$766,290 | 130 | Direct | |
| Dec 19, 2025 | Common Stock | MOption exerciseAcquired | +2,000 | $120.26 | +$240,520 | 2,130 | Direct | |
| Dec 19, 2025 | Common Stock | SSaleDisposed | −500 | $505.45 | −$252,725 | 1,630 | Direct | |
| Dec 19, 2025 | Common Stock | SSaleDisposed | −1,500 | $507.61F6 | −$761,415 | 130 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | Common Stock | MOption exerciseDisposed | −4,000 | $0.00 | $0 | 6,000 | Direct | |
| Dec 18, 2025 | Common Stock | MOption exerciseDisposed | −4,000 | $0.00 | $0 | 2,000 | Direct | |
| Dec 19, 2025 | Common Stock | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $500.12 to $500.725. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $501.13 to $501.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $507.00 to $507.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $510.445 to $511.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $507.58 to $507.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.